RA DRUM
Therapeutic drug monitoring in patients with rheumatoid arthritis (RA-DRUM)
Project managers
Post doc
ABOUT THE PROJECT
RA-DRUM is a clinical study to investigate whether therapeutic drug monitoring (TDM) improves the effect of biological drugs in the treatment of arthritis. With TDM, the amount of drug in blood samples from the patient, the serum concentration, is measured, and the dosage is adjusted to achieve a serum concentration at the right level. One of the reasons why there is a large variation in serum concentration between different patients is that the body's immune system in some patients can react to the drugs and neutralize the effect. By maintaining a high enough serum level of the drug, we believe that we can counteract this process. RA-DRUM is part of the SQUEEZE project, which is a European collaboration that has received over NOK 100 million for arthritis research from Horizon Europe, the EU's research programme.
WHO CAN JOIN?
Patients over the age of 18 diagnosed with rheumatoid arthritis (arthritis) who are treated with biological medicines. Recruitment of participants has not yet begun.
WHAT DOES THE STUDY INCLUDE?
More information about the SQUEEZE project, of which RA-DRUM is a part:
https://www.remedy-senter.no/project/squeeze
https://squeeze-project.eu/
This project has received funding from the European Union's Horizon Europe research and innovation program under grant agreement no. 101095052. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Unior nor the granting authority can be held responsible for them.